Globus Medical (GMED) Enterprise Value (2012 - 2026)

Globus Medical (GMED) has reported Enterprise Value for 15 consecutive years, with $10.0 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Enterprise Value rose 29.34% year-over-year to $10.0 billion; the trailing twelve-month figure through Jun 2026 stood at $10.0 billion (up 29.34% YoY), and the FY2025 full-year result was $11.3 billion, up 7.3% from the prior year.
• Enterprise Value fell to $10.0 billion in Q2 2026 per GMED's latest filing, from $11.1 billion in the prior quarter.
• Across five years, Enterprise Value topped out at $11.3 billion in Q4 2025 and bottomed at $5.2 billion in Q1 2023.
• Historically, Enterprise Value has averaged $7.8 billion across 5 years, with a median of $7.2 billion in 2022.
• The sharpest annual moves came in 2022 and 2024: Enterprise Value slipped 29.65% in 2022, then surged 63.56% in 2024.
• Over 5 years, Enterprise Value stood at $7.0 billion in 2022, then dropped by 4.39% to $6.7 billion in 2023, then soared by 56.6% to $10.5 billion in 2024, then grew by 7.3% to $11.3 billion in 2025, then decreased by 11.01% to $10.0 billion in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered $10.0 billion, $11.1 billion, and $11.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.